Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-06-04

Clinical Trial Update: ROLE OF PROPHYLACTIC TRANEXAMIC ACID IN PREVENTION OF POST-PARTUM HEMORRHAGE IN ELLSCS [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating prophylactic tranexamic acid to prevent postpartum hemorrhage, status not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: Patel Hospital, Pakistan | Conditions: Post Partum Hemorrhage | Phase 1 | Status: NOT_YET_RECRUITING